93 related articles for article (PubMed ID: 9425291)
1. Role of E boxes in the repression of E-cadherin expression.
Giroldi LA; Bringuier PP; de Weijert M; Jansen C; van Bokhoven A; Schalken JA
Biochem Biophys Res Commun; 1997 Dec; 241(2):453-8. PubMed ID: 9425291
[TBL] [Abstract][Full Text] [Related]
2. Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elements.
Hajra KM; Ji X; Fearon ER
Oncogene; 1999 Dec; 18(51):7274-9. PubMed ID: 10602481
[TBL] [Abstract][Full Text] [Related]
3. Regulation of E-cadherin gene expression during tumor progression: the role of a new Ets-binding site and the E-pal element.
Rodrigo I; Cato AC; Cano A
Exp Cell Res; 1999 May; 248(2):358-71. PubMed ID: 10222128
[TBL] [Abstract][Full Text] [Related]
4. Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo.
Hennig G; Behrens J; Truss M; Frisch S; Reichmann E; Birchmeier W
Oncogene; 1995 Aug; 11(3):475-84. PubMed ID: 7630631
[TBL] [Abstract][Full Text] [Related]
5. Sp1/Sp3 and the myeloid zinc finger gene MZF1 regulate the human N-cadherin promoter in osteoblasts.
Le Mée S; Fromigué O; Marie PJ
Exp Cell Res; 2005 Jan; 302(1):129-42. PubMed ID: 15541732
[TBL] [Abstract][Full Text] [Related]
6. Isolation and initial characterization of the BRCA2 promoter.
Davis PL; Miron A; Andersen LM; Iglehart JD; Marks JR
Oncogene; 1999 Oct; 18(44):6000-12. PubMed ID: 10557089
[TBL] [Abstract][Full Text] [Related]
7. Promoter methylation regulates cadherin switching in squamous cell carcinoma.
Chen Q; Lipkina G; Song Q; Kramer RH
Biochem Biophys Res Commun; 2004 Mar; 315(4):850-6. PubMed ID: 14985090
[TBL] [Abstract][Full Text] [Related]
8. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
9. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.
Kao RH; Huang LC; Hsu YH
Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040
[TBL] [Abstract][Full Text] [Related]
10. Upstream stimulatory factor regulates E box-dependent PAI-1 transcription in human epidermal keratinocytes.
Allen RR; Qi L; Higgins PJ
J Cell Physiol; 2005 Apr; 203(1):156-65. PubMed ID: 15372465
[TBL] [Abstract][Full Text] [Related]
11. TAL-1/SCL and its partners E47 and LMO2 up-regulate VE-cadherin expression in endothelial cells.
Deleuze V; Chalhoub E; El-Hajj R; Dohet C; Le Clech M; Couraud PO; Huber P; Mathieu D
Mol Cell Biol; 2007 Apr; 27(7):2687-97. PubMed ID: 17242194
[TBL] [Abstract][Full Text] [Related]
12. Constitutive expression of the Id-1 promoter in human metastatic breast cancer cells is linked with the loss of NF-1/Rb/HDAC-1 transcription repressor complex.
Singh J; Murata K; Itahana Y; Desprez PY
Oncogene; 2002 Mar; 21(12):1812-22. PubMed ID: 11896613
[TBL] [Abstract][Full Text] [Related]
13. Mutant E-cadherin breast cancer cells do not display constitutive Wnt signaling.
van de Wetering M; Barker N; Harkes IC; van der Heyden M; Dijk NJ; Hollestelle A; Klijn JG; Clevers H; Schutte M
Cancer Res; 2001 Jan; 61(1):278-84. PubMed ID: 11196175
[TBL] [Abstract][Full Text] [Related]
14. The UV responsive elements in the human mimecan promoter: a functional characterization.
Tasheva ES; Conrad GW
Mol Vis; 2003 Jan; 9():1-9. PubMed ID: 12533723
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G
Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
[TBL] [Abstract][Full Text] [Related]
16. Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial-mesenchymal transition.
Mejlvang J; Kriajevska M; Berditchevski F; Bronstein I; Lukanidin EM; Pringle JH; Mellon JK; Tulchinsky EM
Exp Cell Res; 2007 Jan; 313(2):380-93. PubMed ID: 17141758
[TBL] [Abstract][Full Text] [Related]
17. Opposite transcriptional activity between the wild type c-myc gene coding for c-Myc1 and c-Myc2 proteins and c-Myc1 and c-Myc2 separately.
Batsché E; Crémisi C
Oncogene; 1999 Oct; 18(41):5662-71. PubMed ID: 10523846
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1.
Lee JO; Kwun HJ; Jung JK; Choi KH; Min DS; Jang KL
Oncogene; 2005 Oct; 24(44):6617-25. PubMed ID: 16007161
[TBL] [Abstract][Full Text] [Related]
19. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features.
Wei Y; Van Nhieu JT; Prigent S; Srivatanakul P; Tiollais P; Buendia MA
Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663
[TBL] [Abstract][Full Text] [Related]
20. Tbx3 represses E-cadherin expression and enhances melanoma invasiveness.
Rodriguez M; Aladowicz E; Lanfrancone L; Goding CR
Cancer Res; 2008 Oct; 68(19):7872-81. PubMed ID: 18829543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
